A 52-year-old woman with type 2 diabetes on metformin monotherapy (HbA1c 7.8%) develops progressive renal impairment (eGFR now 28 mL/min/1.73m²). Metformin must be discontinued due to lactic acidosis risk. What is the most appropriate first-line agent to add or switch to for glucose control?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.